LAMBERTO TAN: Open Payments
NPI 1023022159 · BAYVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 25 payments from 7 companies in 2025. Trend: 2023 $407 · 2024 $556 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $153 |
| Teva Pharmaceuticals USA, Inc. | 6 | $106 |
| Alkermes, Inc. | 4 | $71 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: INVEGA SUSTENNA, UZEDY, ARISTADA, INGREZZA, ABILIFY ASIMTUFII, VRAYLAR, COBENFY.
Industry payments across NJ — which companies pay providers there.
